160 related articles for article (PubMed ID: 16866919)
1. In vivo evidence for microglial activation in neurodegenerative dementia.
Cagnin A; Kassiou M; Meikle SR; Banati RB
Acta Neurol Scand Suppl; 2006; 185():107-14. PubMed ID: 16866919
[TBL] [Abstract][Full Text] [Related]
2. In-vivo measurement of activated microglia in dementia.
Cagnin A; Brooks DJ; Kennedy AM; Gunn RN; Myers R; Turkheimer FE; Jones T; Banati RB
Lancet; 2001 Aug; 358(9280):461-7. PubMed ID: 11513911
[TBL] [Abstract][Full Text] [Related]
3. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.
Cagnin A; Taylor-Robinson SD; Forton DM; Banati RB
Gut; 2006 Apr; 55(4):547-53. PubMed ID: 16210399
[TBL] [Abstract][Full Text] [Related]
5. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
Banati RB; Newcombe J; Gunn RN; Cagnin A; Turkheimer F; Heppner F; Price G; Wegner F; Giovannoni G; Miller DH; Perkin GD; Smith T; Hewson AK; Bydder G; Kreutzberg GW; Jones T; Cuzner ML; Myers R
Brain; 2000 Nov; 123 ( Pt 11)():2321-37. PubMed ID: 11050032
[TBL] [Abstract][Full Text] [Related]
6. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Walker DG; Lue LF
Alzheimers Res Ther; 2015 Aug; 7(1):56. PubMed ID: 26286145
[TBL] [Abstract][Full Text] [Related]
7. Ligands for peripheral benzodiazepine binding sites in glial cells.
Kassiou M; Meikle SR; Banati RB
Brain Res Brain Res Rev; 2005 Apr; 48(2):207-10. PubMed ID: 15850659
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of microglial activation in frontotemporal dementia.
Cagnin A; Rossor M; Sampson EL; Mackinnon T; Banati RB
Ann Neurol; 2004 Dec; 56(6):894-7. PubMed ID: 15562429
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain.
Pedersen MD; Minuzzi L; Wirenfeldt M; Meldgaard M; Slidsborg C; Cumming P; Finsen B
Eur J Neurosci; 2006 Aug; 24(4):991-1000. PubMed ID: 16930426
[TBL] [Abstract][Full Text] [Related]
10. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.
Venneti S; Lopresti BJ; Wiley CA
Prog Neurobiol; 2006 Dec; 80(6):308-22. PubMed ID: 17156911
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Gerhard A; Pavese N; Hotton G; Turkheimer F; Es M; Hammers A; Eggert K; Oertel W; Banati RB; Brooks DJ
Neurobiol Dis; 2006 Feb; 21(2):404-12. PubMed ID: 16182554
[TBL] [Abstract][Full Text] [Related]
12. Depiction of microglial activation in aging and dementia: Positron emission tomography with [
Yokokura M; Terada T; Bunai T; Nakaizumi K; Takebayashi K; Iwata Y; Yoshikawa E; Futatsubashi M; Suzuki K; Mori N; Ouchi Y
J Cereb Blood Flow Metab; 2017 Mar; 37(3):877-889. PubMed ID: 27117856
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.
Gerhard A; Trender-Gerhard I; Turkheimer F; Quinn NP; Bhatia KP; Brooks DJ
Mov Disord; 2006 Jan; 21(1):89-93. PubMed ID: 16108021
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria in activated microglia in vitro.
Banati RB; Egensperger R; Maassen A; Hager G; Kreutzberg GW; Graeber MB
J Neurocytol; 2004 Sep; 33(5):535-41. PubMed ID: 15906160
[TBL] [Abstract][Full Text] [Related]
15. Visualising microglial activation in vivo.
Banati RB
Glia; 2002 Nov; 40(2):206-217. PubMed ID: 12379908
[TBL] [Abstract][Full Text] [Related]
16. The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease.
Bonham LW; Sirkis DW; Yokoyama JS
Front Immunol; 2019; 10():1170. PubMed ID: 31214167
[TBL] [Abstract][Full Text] [Related]
17. Microglia and neuroprotection: from in vitro studies to therapeutic applications.
Polazzi E; Monti B
Prog Neurobiol; 2010 Nov; 92(3):293-315. PubMed ID: 20609379
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders.
Sugama S
Med Hypotheses; 2009 Dec; 73(6):1031-4. PubMed ID: 19556067
[TBL] [Abstract][Full Text] [Related]
19. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation.
Minghetti L; Ajmone-Cat MA; De Berardinis MA; De Simone R
Brain Res Brain Res Rev; 2005 Apr; 48(2):251-6. PubMed ID: 15850664
[TBL] [Abstract][Full Text] [Related]
20. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
Langenfurth A; Rinnenthal JL; Vinnakota K; Prinz V; Carlo AS; Stadelmann C; Siffrin V; Peaschke S; Endres M; Heppner F; Glass R; Wolf SA; Kettenmann H
J Neurosci Res; 2014 Mar; 92(3):275-86. PubMed ID: 24323769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
